scholarly journals National Priority Setting of Clinical Practice Guidelines Development for Chronic Disease Management

2015 ◽  
Vol 30 (12) ◽  
pp. 1733 ◽  
Author(s):  
Heui-Sug Jo ◽  
Dong Ik Kim ◽  
Moo-Kyung Oh
2018 ◽  
Vol 42 (6) ◽  
pp. 627 ◽  
Author(s):  
Rebecca O'Hara ◽  
Heather Rowe ◽  
Louise Roufeil ◽  
Jane Fisher

Objective The aim of this study was to determine whether endometriosis meets the definition for chronic disease in Australian policy documents. Methods A qualitative case study approach was used to thematically analyse the definitions contained in Australian chronic disease policy documents and technical reports. The key themes were then compared with descriptions of endometriosis in peer-reviewed literature, clinical practice guidelines and expert consensus statements. Results The search yielded 18 chronic disease documents that provided a definition or characteristics of chronic disease. The thematic analysis identified key elements of chronic diseases pertaining to onset, causation, duration, treatment, disease course and impact (individual and societal). A comparison with endometriosis descriptions indicated that endometriosis meets five of the six chronic disease key elements. Conclusion In Australia, long-term and complex conditions are managed within a chronic disease framework and include mechanisms such as chronic disease management plans (CDMPs) to assist with coordination and management of these conditions. Because endometriosis has most of the characteristics of chronic disease, it could potentially be reframed as a chronic disease in endometriosis clinical practice guidelines and consensus statements. Further, the use of CDMPs may provide a mechanism to promote individualised care and multidisciplinary management of this chronic, enigmatic and debilitating disease. What is known about the topic? In Australia, long-term complex diseases can be managed within a chronic disease framework that include mechanisms for coordinated care such as CDMPs and team care arrangements. Endometriosis is described as an inflammatory, progressive, relapsing and, for some women, debilitating condition, but is rarely described as a chronic disease in the clinical practice guidelines and consensus statements available in Australia. What does this paper add? Endometriosis shares most of the characteristics of a chronic disease so may benefit from chronic disease management systems such as CDMPs. What are the implications for practitioners? CDMPs may be a useful mechanism to coordinate and improve the effectiveness of care for women with endometriosis who experience sustained symptoms of endometriosis.


2019 ◽  
Vol 17 ◽  
pp. S53-S56
Author(s):  
Radim Líčeník ◽  
Jitka Klugarová ◽  
Andrea Pokorná ◽  
Monika Bezděková ◽  
Jiří Jarkovský ◽  
...  

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Zhi-hong Zheng ◽  
Shu-qi Cui ◽  
Xiao-qin Lu ◽  
David Zakus ◽  
Wan-nian Liang ◽  
...  

2010 ◽  
Vol 8 (1) ◽  
Author(s):  
Ludovic Reveiz ◽  
Diana R Tellez ◽  
Juan S Castillo ◽  
Paola A Mosquera ◽  
Marcela Torres ◽  
...  

2015 ◽  
Vol 39 (2) ◽  
pp. 183 ◽  
Author(s):  
Sarah Jansen ◽  
Lauren Ball ◽  
Catherine Lowe

Objective This study explored private practice dietitians’ perceptions of the impact of the Australian Chronic Disease Management (CDM) program on the conduct of their private practice, and the care provided to patients. Methods Twenty-five accredited practising dietitians working in primary care participated in an individual semistructured telephone interview. Interview questions focussed on dietitians’ perceptions of the proportion of patients receiving care through the CDM program, fee structures, adhering to reporting requirements and auditing. Transcript data were thematically analysed using a process of open coding. Results Half of the dietitians (12/25) reported that most of their patients (>75%) received care through the CDM program. Many dietitians (19/25) reported providing identical care to patients using the CDM program and private patients, but most (17/25) described spending substantially longer on administrative tasks for CDM patients. Dietitians experienced pressure from doctors and patients to keep their fees low or to bulk-bill patients using the CDM program. One-third of interviewed dietitians (8/25) expressed concern about the potential to be audited by Medicare. Recommendations to improve the CDM program included increasing the consultation length and subsequent rebate available for dietetic consultations, and increasing the number of consultations to align with dietetic best-practice guidelines. Conclusions The CDM program creates challenges for dietitians working in primary care, including how to sustain the quality of patient-centred care and yet maintain equitable business practices. To ensure the CDM program appropriately assists patients to receive optimal care, further review of the CDM program within the scope of dietetics is required. What is known about the topic? The Australian CDM program is designed to facilitate patients to receive subsidised multidisciplinary care for CDM. Dietetics is the third most utilised allied health profession within the CDM program. What does this paper add? This paper demonstrates that dietitians experience challenges in providing services to patients using the CDM program, including pressure to keep fees down, high administrative load, difficulties accessing clear information on compliance requirements, and face barriers to providing best-practice care to patients with chronic disease. What are the implications for practitioners? Changes to the Australian CDM program are required to help dietitians provide health care in line with best-practice guidelines for CDM, and sustainable business practices.


2017 ◽  
Author(s):  
Molly M Warner ◽  
Jaimon T Kelly ◽  
Dianne P Reidlinger ◽  
Tammy C Hoffmann ◽  
Katrina L Campbell

BACKGROUND Telehealth-delivered dietary interventions are effective for chronic disease management and are an emerging area of clinical practice. However, to apply interventions from the research setting in clinical practice, health professionals need details of each intervention component. OBJECTIVE The aim of this study was to evaluate the completeness of intervention reporting in published dietary chronic disease management trials that used telehealth delivery methods. METHODS Eligible randomized controlled trial publications were identified through a systematic review. The completeness of reporting of experimental and comparison interventions was assessed by two independent assessors using the Template for Intervention Description and Replication (TIDieR) checklist that consists of 12 items including intervention rationale, materials used, procedures, providers, delivery mode, location, when and how much intervention delivered, intervention tailoring, intervention modifications, and fidelity. Where reporting was incomplete, further information was sought from additional published material and through email correspondence with trial authors. RESULTS Within the 37 eligible trials, there were 49 experimental interventions and 37 comparison interventions. One trial reported every TIDieR item for their experimental intervention. No publications reported every item for the comparison intervention. For the experimental interventions, the most commonly reported items were location (96%), mode of delivery (98%), and rationale for the essential intervention elements (96%). Least reported items for experimental interventions were modifications (2%) and intervention material descriptions (39%) and where to access them (20%). Of the 37 authors, 14 responded with further information, and 8 could not be contacted. CONCLUSIONS Many details of the experimental and comparison interventions in telehealth-delivered dietary chronic disease management trials are incompletely reported. This prevents accurate interpretation of trial results and implementation of effective interventions in clinical practice.


2020 ◽  
Vol 33 (4) ◽  
pp. 178-181
Author(s):  
Thilina Bandara ◽  
Richard Musto ◽  
Jesse Kancir ◽  
Cordell Neudorf

During the H1N1 outbreak of 2009, local public health units engaged in consultations with various levels of government to develop clinical practice guidelines. These guidelines provide specific clinical considerations around prevention, management, and treatment associated with the particular pathogen involved and are used by frontline healthcare professionals across many healthcare settings. In this article, we report on the lessons learned by Medical Officers of Health from across Canada on the guideline development and deployment processes and provide suggestions to improve guidelines development and deployment during future pandemic situations.


Sign in / Sign up

Export Citation Format

Share Document